Merck, a leading science and Technology Company in healthcare, and the producer of Seven Seas fish oil products, has contributed Kshs. 25 million to the Beyond Zero Campaign.
The platinum sponsorship package accorded Merck exclusive sponsorship rights of the two kilometer children’s race at the First Lady’s Half Marathon held on March 6th this year.
“We applaud the initiatives the First Lady has been taking to fight malnutrition and related issues like maternal and infant mortality. As a health company, we are committed to further financially support initiatives like Beyond Zero that enable access to better healthcare. In addition, we believe we can play a role in reducing malnutrition by raising awareness about this issue in Kenya,” said Merck Regional Vice President Erich Nobis.
Every year, about 108,000 children die before their fifth birthday with 50 percent of those deaths linked to malnutrition. Vitamin deficiency is also an area of concern.
More 8 in 10 of pre-school going children have micronutrient deficiencies which results in a weaker immune system and puts them at greater risk of disease.
In addition to supporting Beyond Zero, Merck, through its Seven Seas brand, will be launching an awareness campaign in Kenya to actively fight malnutrition. The aim of this campaign is to promote healthy lifestyles and nutrition habits and ultimately help reduce malnutrition in Kenya.
Malnourished children grow up to become malnourished adults who then give birth to malnourished children. The campaign seeks to break the cycle of malnutrition and support Kenya’s objective to build healthier and empowered generations for the future.
Fish oil is one of the most popular food supplements on the market today and is derived from the bodies of several different species of fish and offers a rich source of the Omega-3 nutrients. Merck’s range of cod liver oil products is specifically designed to contribute to meeting recommended vitamin and minerals intake.
“Malnutrition is not a battle that can be won alone. It requires a strong government vision, active cooperation from partners, donors, private sector and involvement from the public. We believe we can play a role in supporting the objective to reduce the number of preventable deaths by 2030 to zero and will continue to do so”, added Mr. Nobis.
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life ; from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials. In 2014, Merck generated sales of € 11.3 billion in 66 countries